Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gossamer Bio (GOSS) Other Non Operating Income (2022 - 2025)

Gossamer Bio's Other Non Operating Income history spans 4 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 75.62% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $9.3 million, down 33.75%, while the annual FY2025 figure was $9.3 million, 33.75% down from the prior year.
  • Other Non Operating Income reached $1.0 million in Q4 2025 per GOSS's latest filing, down from $3.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $6.5 million in Q2 2023 to a low of -$332000.0 in Q3 2022.
  • Average Other Non Operating Income over 4 years is $2.5 million, with a median of $2.7 million recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 1130.12% in 2023, then crashed 75.62% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at $1.5 million in 2022, then surged by 161.54% to $3.8 million in 2023, then grew by 9.53% to $4.2 million in 2024, then plummeted by 75.62% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Other Non Operating Income are $1.0 million (Q4 2025), $3.0 million (Q3 2025), and $2.7 million (Q2 2025).